TNC and breast cancer: In vitro experiments suggested that tenascin-C can induce epithelial-to-mesenchymal transition (EMT) in breast cancer cells via binding to αvβ6 and αvβ1 integrins [259], colorectal [260] and pancreatic cancer cells [261] or promote invadopodia formation in Ewing sarcoma [262].